BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34026427)

  • 1. A Fifteen-Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer.
    Tian X; Wang X; Cui Z; Liu J; Huang X; Shi C; Zhang M; Liu T; Du X; Li R; Huang L; Gong D; Tian R; Cao C; Jin P; Zeng Z; Pan G; Xia M; Zhang H; Luo B; Xie Y; Li X; Li T; Wu J; Zhang Q; Chen G; Hu Z
    Adv Sci (Weinh); 2021 May; 8(10):2001978. PubMed ID: 34026427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial.
    Napolitano U; Imperato F; Mossa B; Framarino ML; Marziani R; Marzetti L
    Eur J Gynaecol Oncol; 2003; 24(1):51-9. PubMed ID: 12691318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer.
    Liang Y; Lü W; Zhang X; Lü B
    Diagn Pathol; 2018 Nov; 13(1):93. PubMed ID: 30474571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
    Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
    Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
    Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of liposomal paclitaxel and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
    Li Y; Wang X; Li J; Ding W
    Eur J Gynaecol Oncol; 2015; 36(1):54-8. PubMed ID: 25872335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
    Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
    J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rs2686344 and serum squamous cell carcinoma antigen could predict clinical efficacy of neoadjuvant chemotherapy for cervical cancer.
    Li T; Huang H; Hu Y; Chen H; Li R; Lu H; Yan L; Chen Y; Zhang C; Zhang Q; Li X
    Curr Probl Cancer; 2021 Dec; 45(6):100755. PubMed ID: 33902928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
    Minig L; Colombo N; Zanagnolo V; Landoni F; Bocciolone L; Cárdenas-Rebollo JM; Iodice S; Maggioni A
    Int J Gynecol Cancer; 2013 Nov; 23(9):1647-54. PubMed ID: 24100590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
    Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of effectiveness between intra-arterial and intra-venous neoadjuvant chemotherapy in stage Ib2-IIb cervical carcinoma].
    Cao DY; Yang JX; Shen K; Xiang Y; Pan LY; Lang JH; Wu M; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):888-91. PubMed ID: 19134324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.
    Salihi R; Leunen K; Moerman P; Amant F; Neven P; Vergote I
    Int J Gynecol Cancer; 2017 Jul; 27(6):1256-1260. PubMed ID: 28574931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma.
    Scandurra G; Scibilia G; Banna GL; D'Agate G; Lipari H; Gieri S; Scollo P
    J Gynecol Oncol; 2015 Apr; 26(2):118-24. PubMed ID: 25686397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
    Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
    Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival.
    Buda A; Lissoni AA; Floriani I; Biagioli E; Gerardi C; Bonazzi C; Chiari S; Locatelli L; Dell'Anna T; Signorelli M; Mangioni C; Milani R
    Int J Gynecol Cancer; 2015 Oct; 25(8):1468-75. PubMed ID: 26222484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy analysis of preoperative neoadjuvant chemotherapy with high-dose dense paclitaxel plus cisplatin in Stages IB2, IIA2, IIB cervical cancer in Iran.
    Mousavi AS; Hashemi FS; Gilani MM; Akhavan S; Shariat M
    Eur J Gynaecol Oncol; 2016; 37(5):703-709. PubMed ID: 29787015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neoadjuvant chemotherapy in locally advanced squamous carcinoma of the uterine cervix (IB2 - IIIB stage)].
    Kornovski Ia; Ianeva R; Gorchev G; Tsekov Kh; Uzunov S; Filev S
    Akush Ginekol (Sofiia); 2002; 41(4):39-44. PubMed ID: 12516261
    [No Abstract]   [Full Text] [Related]  

  • 19. Transrectal ultrasound and magnetic resonance imaging in the evaluation of tumor size following neoadjuvant chemotherapy for locally advanced cervical cancer.
    Pinkavova I; Fischerova D; Zikan M; Burgetova A; Slama J; Svarovsky J; Dundr P; Dusek L; Cibula D
    Ultrasound Obstet Gynecol; 2013 Dec; 42(6):705-12. PubMed ID: 23495185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic T1 Perfusion magnetic resonance imaging evaluation of the therapeutic effect of neoadjuvant chemotherapy in locally advanced cervical cancer.
    Fu C; Feng X; Bian D; Du W; Wang X; Zhao Y
    Int J Gynecol Cancer; 2013 Sep; 23(7):1270-8. PubMed ID: 23970155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.